T regs in fibrosis: To know your enemy, you must become your enemy
Open Access
- 13 September 2019
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (39), eaay1160
- https://doi.org/10.1126/sciimmunol.aay1160
Abstract
T helper 2–skewed regulatory T cells in the skin use GATA3 to suppress local profibrotic type 2 cytokine production. See the related Research Article by Kalekar et al .Keywords
This publication has 10 references indexed in Scilit:
- Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responsesScience Immunology, 2019
- Type 2 immunity in tissue repair and fibrosisNature Reviews Immunology, 2017
- Harnessing the plasticity of CD4+ T cells to treat immune-mediated diseaseNature Reviews Immunology, 2016
- Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosisJournal of Allergy and Clinical Immunology, 2015
- GATA-3 Function in Innate and Adaptive ImmunityImmunity, 2014
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Regulatory T Cells: Mechanisms of Differentiation and FunctionAnnual Review of Immunology, 2012
- GATA3 controls Foxp3+ regulatory T cell fate during inflammation in miceJCI Insight, 2011
- An Essential Role of the Transcription Factor GATA-3 for the Function of Regulatory T CellsImmunity, 2011
- Foxp3+ regulatory T cells maintain immune homeostasis in the skinThe Journal of Experimental Medicine, 2008